AMG Critical Materials N.V. (AMVMF) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for AMG Critical Materials N.V. (AMVMF).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Overview

Price & Market Data

Price: $16.70

Daily Change: $0.00 / 0.00%

Range: $0 - $0

Market Cap: $569,792,320

Volume: 0

Performance Metrics

1 Week: -0.04%

1 Month: -12.11%

3 Months: 23.07%

6 Months: -4.57%

1 Year: -35.02%

YTD: 21.10%

Company Details

Employees: 3651

Sector: Non-energy minerals

Industry: Other metals/Minerals

Country: Netherlands

Details

AMG Critical Materials N.V. develops, produces, and sells energy storage materials. The company operates through three segments: AMG Lithium, AMG Vanadium, and AMG Technologies. It offers engineered specialty metal products and vacuum furnaces for specialized alloying applications; and heat treatment services. The company also provides lithium, niobium, tantalum, and feldspar; aluminum master alloys and powders, ferrovanadium, chrome metal, and titanium alloys; and LIVA batteries, processed natural graphite, antimony oxide, and silicon metals. In addition, it offers vanadium and tantalum; operates a value chain with mining and solid state lithium batteries; advanced metallurgy; advanced vacuum furnace systems; engineering equipment to the aerospace engine sector; antimony trioxide; and titanium aluminides. The company primarily operates in the United States, China, Germany, France, Italy, Brazil, the United Kingdom, Japan, Canada, India, Austria, Mexico, Belgium, Poland, Switzerland, Turkey, Spain, Thailand, Sweden, the Czech Republic, the Netherlands, South Korea, Australia, Taiwan, Kazakhstan, Argentina, Singapore, and internationally. It serves energy, transportation, infrastructure, specialty metals, and chemicals industries. The company was formerly known as AMG Advanced Metallurgical Group N.V. and changed its name to AMG Critical Materials N.V. in May 2023. AMG Critical Materials N.V. was incorporated in 2006 and is headquartered in Amsterdam, the Netherlands.

Selected stocks

Regen Biopharma, Inc. (RGBPP)

GSK plc (GLAXF)

Genflow Biosciences Plc (GENFF)